Vanguard Group Inc Rezolute, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Rezolute, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,553,352 shares of RZLT stock, worth $6.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,553,352
Previous 1,407,652
10.35%
Holding current value
$6.54 Million
Previous $1.39 Million
184.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RZLT
# of Institutions
33Shares Held
26.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$42.7 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.02MShares$12.7 Million0.5% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$11.8 Million0.95% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.6MShares$6.74 Million0.59% of portfolio
-
Blackstone Inc New York, NY1.54MShares$6.47 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $163M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...